- Home
- SMBK vs KURA Comparison
SMBK vs KURA Comparison
Compare SMBK & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SMBK | KURA |
|---|---|---|
| Founded | N/A | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 706.2M | 744.0M |
| IPO Year | 2000 | 2015 |
Fundamental Metrics
Financial Performance| Metric | SMBK | KURA |
|---|---|---|
| Price | $37.66 | $8.41 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $38.63 | $26.50 |
| AVG Volume (30 Days) | 48.2K | ★ 1.4M |
| Earning Date | 04-20-2026 | 03-05-2026 |
| Dividend Yield | ★ 0.85% | N/A |
| EPS Growth | ★ 39.25 | N/A |
| EPS | ★ 2.98 | N/A |
| Revenue | N/A | ★ $67,482,000.00 |
| Revenue This Year | $17.59 | $124.03 |
| Revenue Next Year | $10.30 | $28.63 |
| P/E Ratio | $12.61 | ★ N/A |
| Revenue Growth | N/A | ★ 25.24 |
| 52 Week Low | $26.31 | $5.41 |
| 52 Week High | $43.91 | $12.49 |
Technical Indicators
Market Signals| Indicator | SMBK | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 35.79 | 43.47 |
| Support Level | $35.74 | $7.99 |
| Resistance Level | $40.08 | $10.50 |
| Average True Range (ATR) | 1.38 | 0.41 |
| MACD | -0.16 | -0.02 |
| Stochastic Oscillator | 21.00 | 33.33 |
Price Performance
Historical ComparisonAbout SMBK SmartFinancial Inc.
SmartFinancial Inc operates as a bank holding company for SmartBank. It offers various banking and financial services to individuals and corporate customers. The principal business of the Bank consists of attracting deposits from the general public and investing those funds, together with funds generated from operations and from principal and interest payments on loans, mainly in commercial loans, commercial and residential real estate loans, consumer loans, and residential and commercial construction loans. The primary source of revenue is interest income from earning assets, namely loans and securities.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.